Association of human papillomavirus viral load with HPV16 and high-grade intraepithelial lesion

International Journal of Gynecological Cancer

Volumn 13, Issue 2, 2003, Pages 154-158

  Abba, M C ^a   Mouron S A ^a   Gomez M A ^a   Dulout, F N ^a   Golijow, C D ^a  

^a FACULTAD DE CIENCIAS VETERINARIAS   (Argentina)

Author keywords

HPV; Intraepithelial lesion; Viral load

Indexed keywords

DNA; VIRUS DNA;

ADULT; ARTICLE; CANCER GRADING; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; CYTODIAGNOSIS; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMA VIRUS 31; HUMAN PAPILLOMA VIRUS 51; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN TISSUE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU; VIRUS LOAD; VIRUS REPLICATION; VIRUS TYPING; WART VIRUS; CLASSIFICATION; ISOLATION AND PURIFICATION; PAPILLOMA VIRUS; PATHOLOGY; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VIRAL LOAD;

EID: 0037969847     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2003.13011.x     Document Type: Article

References (21)

1. Farias-Eisner R, Casey A, Walker D, Shaper A, Berek J. Cervix, vagina and vulva. In: Abeloff, M Armitage, J Lichter, A Niederhuber, J, eds. Clinical Oncology. New York: Churchill Livingstone, 1995:1527-68.
2. IARC. Monograph on the evaluation of carcinogenic risks to humans. 64. Human papillomaviruses. Lyon, France: International Agency for Research on Cancer, 1995.
3. Zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000;92:690-8.
4. Josefsson AM, Magnusson PKE, Ylitalo N et al. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 2000;355:2189-93.
5. Johnston C. Quantitative test for human papillomavirus. Lancet 2000;355:2179-80.
6. Swan DC, Tucker RA, Tortolero-Luna G et al. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J Clin Microbiol 1999;37:1030-4.
7. Ylitalo N, Sørensen P, Josefsson AM et al. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: nested case-control study. Lancet, 2000;355:2194-98.
8. Ho GYF, Palan PR, Basu J et al. Viral characteristics of Human papillomavirus infection and antioxidant levels as risk factors for cervical dysplasia. Int J Cancer 1998;78:594-9.
9. Serth J, Panitz F, Paeslack U, Kucyk MA, Jonas U. Increased levels of Human papillomavirus type 16 DNA in subset of prostate cancers. Cancer Res, 1999;59:823-5.
10. Mourón SA, Abba MC, Guerci A, Gómez MA, Dulout FN, Golijow CD. Association between activated K-ras and c-erbB-2 oncogenes with 'high-risk' and 'low-risk' Human Papilloma Virus types in preinvasive cervical lesions. Mut Res, 2000;469:127-34.
11. Ting Y, Manos MM. Detection and typing of genital Human Papillomavirus. In: Innis, MA Gelfant, DH Sneinsky, JJ White, TJ, eds. PCR Protocols. San Diego: Academic Press, 1990:356-67.
12. Evander M, Edlund K, Bodun E. Comparison of a one-step and two-step polymerase chain reaction with the degenerate general primers in a population-based study of Human Papillomavirus infection in young Swedish women. J Clin Microbiol 1992;30:987.
13. Drut R, Drut RM, Gómez MA, Cueto Rua E, Lojo MM. Presence of Human Papillomavirus in extrahepatic biliary atresia. J Pediatr Gastroenterol Nutri 1998;27:530-5.
14. Golijow CD, Mourón SA, Gómez MA, Dulout FN. Differences in K-ras codon 12 mutation frequency between 'high-risk' and 'low-risk' HPV-infected samples. Gynecol Oncol 1999;75:108-12.
15. Caballero OL, Villa LL, Simpson AJ. Low stringency-PCR (LS-PCR) allows entirely internally standardized DNA quantitation. Nucl Acids Res 1995;23:192-3.
16. Caballero OL, Dias Neto E, Koury MC et al. Low-stringency PCR provides an internal control for negative results in PCR-based diagnosis. PCR Meth Appl 1994;3:305-7.
17. Nobbenhuis MAE, Walboomers JMM, Helmerhost TJM et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 1999;354:20-5.
18. Walli KL, Wiklund F, Angstön T et al. Type-specific persistance of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 1999;341:1633-8.
19. Yoshinouchi M, Hongo A, Nakamura K et al. Analysis by multiplex PCR of the physical status of human papillomavirus type 16 DNA in cervical cancer. J Clin Microbiol 1999;37:3514-7.
20. Bosch F, Manos M, Muñoz N. Prevalence of Human papillomavirus in cervical cancer. A worlwide perspective. J Natl Cancer Inst 1995;87:796-802.
21. Franco E, Rohan L, Villa L. Epidemiologic evidence and Human papillomavirus infection as a necessary cause of cervical cancer. J Natl Cancer Inst 1999;9:506-11.